Li Zhu

5PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 10, 2026
PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.

|Aug 13, 2025
Sequential treatment with PARPi and WEE1i enhances antitumor immune responses in preclinical models of ovarian cancer.

Xiaofei Jiao, Jiahao Liu, Yijie Wu

|May 07, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.

Jiahao Liu, Xiaofei Jiao, Wei Mu

|Jul 25, 2022
Monitoring anti-CD19 chimeric antigen receptor T cell population by flow cytometry and its consistency with digital droplet polymerase chain reaction.

Jiali Cheng, Xia Mao, Caixia Chen

|Feb 04, 2020
Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis.

Zheng Liu, Jianjun Chen, Lei Cheng

Pageof 1

Frequent Collaborators

3 joint publications

Yong Fang

2 joint publications

Guang Hu

2 joint publications

Gordon B Mills

2 joint publications

Qing Zhong